Credit Suisse’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $886K | Buy |
180,148
+8,141
| +5% | +$40.1K | ﹤0.01% | 2332 |
|
|
2023
Q4 | $1.51M | Buy |
172,007
+31,392
| +22% | +$276K | ﹤0.01% | 2064 |
|
|
2023
Q3 | $1.61M | Sell |
140,615
-1,573
| -1% | -$18K | ﹤0.01% | 1957 |
|
|
2023
Q2 | $3.6M | Buy |
142,188
+3,342
| +2% | +$84.6K | ﹤0.01% | 1538 |
|
|
2023
Q1 | $4.47M | Buy |
138,846
+8,841
| +7% | +$285K | ﹤0.01% | 1382 |
|
|
2022
Q4 | $2.4M | Buy |
130,005
+32,752
| +34% | +$605K | ﹤0.01% | 1758 |
|
|
2022
Q3 | $2.63M | Buy |
97,253
+6,376
| +7% | +$172K | ﹤0.01% | 1651 |
|
|
2022
Q2 | $1.26M | Buy |
90,877
+224
| +0.2% | +$3.09K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $1.77M | Buy |
90,653
+5,683
| +7% | +$111K | ﹤0.01% | 2158 |
|
|
2021
Q4 | $1.39M | Sell |
84,970
-1,086
| -1% | -$17.7K | ﹤0.01% | 2370 |
|
|
2021
Q3 | $2.4M | Buy |
86,056
+3,761
| +5% | +$105K | ﹤0.01% | 2034 |
|
|
2021
Q2 | $2.44M | Sell |
82,295
-3,607
| -4% | -$107K | ﹤0.01% | 2058 |
|
|
2021
Q1 | $2.4M | Sell |
85,902
-21,598
| -20% | -$604K | ﹤0.01% | 2029 |
|
|
2020
Q4 | $3.05M | Buy |
107,500
+51,109
| +91% | +$1.45M | ﹤0.01% | 1864 |
|
|
2020
Q3 | $1.42M | Buy |
56,391
+6,927
| +14% | +$174K | ﹤0.01% | 2044 |
|
|
2020
Q2 | $1.21M | Sell |
49,464
-10,076
| -17% | -$246K | ﹤0.01% | 2199 |
|
|
2020
Q1 | $881K | Buy |
59,540
+24,528
| +70% | +$363K | ﹤0.01% | 2203 |
|
|
2019
Q4 | $568K | Buy |
35,012
+7,967
| +29% | +$129K | ﹤0.01% | 2849 |
|
|
2019
Q3 | $352K | Sell |
27,045
-1,962
| -7% | -$25.5K | ﹤0.01% | 2968 |
|
|
2019
Q2 | $376K | Buy |
29,007
+5,378
| +23% | +$69.7K | ﹤0.01% | 2934 |
|
|
2019
Q1 | $373K | Buy |
23,629
+3,849
| +19% | +$60.8K | ﹤0.01% | 2922 |
|
|
2018
Q4 | $398K | Buy |
19,780
+2,462
| +14% | +$49.5K | ﹤0.01% | 2860 |
|
|
2018
Q3 | $431K | Sell |
17,318
-7,491
| -30% | -$186K | ﹤0.01% | 2914 |
|
|
2018
Q2 | $682K | Sell |
24,809
-766
| -3% | -$21.1K | ﹤0.01% | 2827 |
|
|
2018
Q1 | $788K | Sell |
25,575
-2,491
| -9% | -$76.8K | ﹤0.01% | 2722 |
|
|
2017
Q4 | $1M | Buy |
28,066
+3,693
| +15% | +$132K | ﹤0.01% | 2531 |
|
|
2017
Q3 | $670K | Buy |
24,373
+11,767
| +93% | +$323K | ﹤0.01% | 2905 |
|
|
2017
Q2 | $332K | Sell |
12,606
-560
| -4% | -$14.7K | ﹤0.01% | 3021 |
|
|
2017
Q1 | $274K | Sell |
13,166
-4,912
| -27% | -$102K | ﹤0.01% | 3174 |
|
|
2016
Q4 | $374K | Sell |
18,078
-4,808
| -21% | -$99.5K | ﹤0.01% | 3212 |
|
|
2016
Q3 | $371K | Sell |
22,886
-1,966
| -8% | -$31.9K | ﹤0.01% | 3239 |
|
|
2016
Q2 | $338K | Sell |
24,852
-14,431
| -37% | -$196K | ﹤0.01% | 3342 |
|
|
2016
Q1 | $685K | Buy |
39,283
+22,477
| +134% | +$392K | ﹤0.01% | 2726 |
|
|
2015
Q4 | $574K | Buy |
16,806
+2,345
| +16% | +$80.1K | ﹤0.01% | 3053 |
|
|
2015
Q3 | $430K | Sell |
14,461
-22,637
| -61% | -$673K | ﹤0.01% | 3302 |
|
|
2015
Q2 | $1.19M | Buy |
37,098
+11,604
| +46% | +$371K | ﹤0.01% | 2770 |
|
|
2015
Q1 | $529K | Sell |
25,494
-11,914
| -32% | -$247K | ﹤0.01% | 3249 |
|
|
2014
Q4 | $633K | Buy |
37,408
+18,935
| +103% | +$320K | ﹤0.01% | 3186 |
|
|
2014
Q3 | $357K | Buy |
18,473
+11,407
| +161% | +$220K | ﹤0.01% | 3453 |
|
|
2014
Q2 | $240K | Buy |
+7,066
| New | +$240K | ﹤0.01% | 3820 |
|